Los Angeles Capital Management LLC decreased its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 73.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 244,487 shares of the biotechnology company’s stock after selling 683,012 shares during the period. Los Angeles […]